Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG
Antibody therapy of cancer is increasingly used in the clinic and has improved patient's life expectancy. Except for immune checkpoint inhibition, the mode of action of many antibodies is to recognize overexpressed or specific tumor antigens and initiate either direct F(ab′)2-mediated tumor cel...
Main Authors: | Arianne M. Brandsma, Sina Bondza, Mitchell Evers, Rosanne Koutstaal, Maaike Nederend, J. H. Marco Jansen, Thies Rösner, Thomas Valerius, Jeanette H. W. Leusen, Toine ten Broeke |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00704/full |
Similar Items
-
Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents
by: Geert van Tetering, et al.
Published: (2020-12-01) -
Improvement of the method of obtaining human IgA Fc-fragments
by: O. Y. Galkin, et al.
Published: (2015-02-01) -
Advances in therapeutic Fc engineering - modulation of IgG associated effector functions and serum half-life
by: Abhishek Saxena, et al.
Published: (2016-12-01) -
Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells
by: Kristin M. Snyder, et al.
Published: (2018-12-01) -
Deciphering Fc-mediated Antiviral Antibody Functions in Animal Models
by: Alan L. Schmaljohn, et al.
Published: (2019-07-01)